Cargando…
Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy
OBJECTIVE: Although metastasis of hepatocellular carcinoma to the brain is uncommon, it is associated with a very high mortality rate and most patients usually expire within 1 year after brain metastasis. The aim of this study is to identify the effectiveness of the active interventions such as gamm...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Brain Tumor Society and The Korean Society for Neuro-Oncology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027101/ https://www.ncbi.nlm.nih.gov/pubmed/24904896 http://dx.doi.org/10.14791/btrt.2013.1.2.78 |
_version_ | 1782316949792882688 |
---|---|
author | Park, Tae Yong Na, Young Chul Lee, Won Hee Kim, Ji Hee Chang, Won Seok Jung, Hyun Ho Chang, Jong Hee Chang, Jin Woo Park, Young Gou |
author_facet | Park, Tae Yong Na, Young Chul Lee, Won Hee Kim, Ji Hee Chang, Won Seok Jung, Hyun Ho Chang, Jong Hee Chang, Jin Woo Park, Young Gou |
author_sort | Park, Tae Yong |
collection | PubMed |
description | OBJECTIVE: Although metastasis of hepatocellular carcinoma to the brain is uncommon, it is associated with a very high mortality rate and most patients usually expire within 1 year after brain metastasis. The aim of this study is to identify the effectiveness of the active interventions such as gamma knife radiosurgery or surgical intervention for these patients. METHODS: We retrospectively reviewed the medical records and imaging data of 59 patients with metastatic brain tumors from hepatocellular carcinoma from May 2004 to September 2012. The study included patients with available clinical and radiological data who had been diagnosed with metastatic hepatocellular carcinoma of the brain, confirmed by magnetic resonance imaging. The overall survival time was analyzed and compared according to each risk factor. RESULTS: The mean age at diagnosis of metastatic brain tumor was 52.2 years (14-77). The mean follow-up duration was 13.3 weeks (0.1-117.6). Overall median survival was 4.3 weeks (95% confidence interval, 2.2-6.4). The results from an analysis of clinical factors related to survival revealed that treatment modalities were significantly related to the patient's survival (log rank, p=0.006). Twenty patients (32.8%) experienced tumor bleeding, and the survival time of the patients with tumor bleeding tended to be shorter, although the result was not statistically significant (log rank, p=0.058). Hepatic reserve, by Child-Pugh classification, was grade A in 38 patients (64.4%), grade B in 16 patients (27.1%), and grade C in 5 patients (8.5%), and was significantly related to the patient's survival (log rank, p=0.000). CONCLUSION: Although patients with metastatic brain tumors from hepatocellular carcinoma showed poor survival, active intervention including surgical resection or gamma knife radiosurgery may result in better survival, especially if patients have preserved liver function. |
format | Online Article Text |
id | pubmed-4027101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | The Korean Brain Tumor Society and The Korean Society for Neuro-Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-40271012014-06-05 Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy Park, Tae Yong Na, Young Chul Lee, Won Hee Kim, Ji Hee Chang, Won Seok Jung, Hyun Ho Chang, Jong Hee Chang, Jin Woo Park, Young Gou Brain Tumor Res Treat Original Article OBJECTIVE: Although metastasis of hepatocellular carcinoma to the brain is uncommon, it is associated with a very high mortality rate and most patients usually expire within 1 year after brain metastasis. The aim of this study is to identify the effectiveness of the active interventions such as gamma knife radiosurgery or surgical intervention for these patients. METHODS: We retrospectively reviewed the medical records and imaging data of 59 patients with metastatic brain tumors from hepatocellular carcinoma from May 2004 to September 2012. The study included patients with available clinical and radiological data who had been diagnosed with metastatic hepatocellular carcinoma of the brain, confirmed by magnetic resonance imaging. The overall survival time was analyzed and compared according to each risk factor. RESULTS: The mean age at diagnosis of metastatic brain tumor was 52.2 years (14-77). The mean follow-up duration was 13.3 weeks (0.1-117.6). Overall median survival was 4.3 weeks (95% confidence interval, 2.2-6.4). The results from an analysis of clinical factors related to survival revealed that treatment modalities were significantly related to the patient's survival (log rank, p=0.006). Twenty patients (32.8%) experienced tumor bleeding, and the survival time of the patients with tumor bleeding tended to be shorter, although the result was not statistically significant (log rank, p=0.058). Hepatic reserve, by Child-Pugh classification, was grade A in 38 patients (64.4%), grade B in 16 patients (27.1%), and grade C in 5 patients (8.5%), and was significantly related to the patient's survival (log rank, p=0.000). CONCLUSION: Although patients with metastatic brain tumors from hepatocellular carcinoma showed poor survival, active intervention including surgical resection or gamma knife radiosurgery may result in better survival, especially if patients have preserved liver function. The Korean Brain Tumor Society and The Korean Society for Neuro-Oncology 2013-10 2013-10-31 /pmc/articles/PMC4027101/ /pubmed/24904896 http://dx.doi.org/10.14791/btrt.2013.1.2.78 Text en Copyright © 2013 The Korean Brain Tumor Society and The Korean Society for Neuro-Oncology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Park, Tae Yong Na, Young Chul Lee, Won Hee Kim, Ji Hee Chang, Won Seok Jung, Hyun Ho Chang, Jong Hee Chang, Jin Woo Park, Young Gou Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy |
title | Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy |
title_full | Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy |
title_fullStr | Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy |
title_full_unstemmed | Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy |
title_short | Treatment Options of Metastatic Brain Tumors from Hepatocellular Carcinoma: Surgical Resection vs. Gamma Knife Radiosurgery vs. Whole Brain Radiation Therapy |
title_sort | treatment options of metastatic brain tumors from hepatocellular carcinoma: surgical resection vs. gamma knife radiosurgery vs. whole brain radiation therapy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027101/ https://www.ncbi.nlm.nih.gov/pubmed/24904896 http://dx.doi.org/10.14791/btrt.2013.1.2.78 |
work_keys_str_mv | AT parktaeyong treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy AT nayoungchul treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy AT leewonhee treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy AT kimjihee treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy AT changwonseok treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy AT junghyunho treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy AT changjonghee treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy AT changjinwoo treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy AT parkyounggou treatmentoptionsofmetastaticbraintumorsfromhepatocellularcarcinomasurgicalresectionvsgammakniferadiosurgeryvswholebrainradiationtherapy |